Serologic and Immunologic Studies in Patients With AIDS in North America and Africa

The Potential Role of Infectious Agents as Cofactors in Human Immunodeficiency Virus Infection

Thomas C Quinn, Peter Piot, Joseph B. Mccormick, Fred M. Feinsod, Henry Taelman, Bela Kapita, Wim Stevens, Anthony S. Fauci

Research output: Contribution to journalArticle

Abstract

Serologic and immunologic studies were performed in 38 African and 60 US patients with acquired immunodeficiency syndrome (AIDS), 100 African and 100 US heterosexual men and women, and 100 US homosexual men to examine the potential role of infectious agents in human immunodeficiency virus (HIV) infection. There were no significant differences in the prevalence of antibodies to cytomegalovirus, Epstein-Barr virus, hepatitis A and B viruses, herpes simplex virus, syphilis, and toxoplasmosis among the African and US patients with AIDS, African heterosexual controls, and US homosexual men. However, these four groups all demonstrated a significantly greater prevalence of antibodies to each of these infectious agents compared with US heterosexual men. Immunologic studies demonstrated a significant elevation of activated lymphocytes (HLA-DR and T3 positive) and immune complexes in both AIDS populations and African heterosexual and US homosexual populations, compared with the US heterosexual population. These data demonstrate that the immune systems of African heterosexuals, similar to those of US homosexual men, are in a chronically activated state associated with chronic viral and parasitic antigenic exposure, which may cause them to be particularly susceptible to HIV infection or disease progression.

Original languageEnglish (US)
Pages (from-to)2617-2621
Number of pages5
JournalJournal of the American Medical Association
Volume257
Issue number19
DOIs
StatePublished - May 15 1987

Fingerprint

Northern Africa
Heterosexuality
Virus Diseases
North America
Acquired Immunodeficiency Syndrome
HIV
CD3 Antigens
Population
Hepatitis A virus
Antibodies
Toxoplasmosis
HLA-DR Antigens
Simplexvirus
Syphilis
Antigen-Antibody Complex
Cytomegalovirus
Human Herpesvirus 4
Hepatitis B virus
Disease Progression
Immune System

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Serologic and Immunologic Studies in Patients With AIDS in North America and Africa : The Potential Role of Infectious Agents as Cofactors in Human Immunodeficiency Virus Infection. / Quinn, Thomas C; Piot, Peter; Mccormick, Joseph B.; Feinsod, Fred M.; Taelman, Henry; Kapita, Bela; Stevens, Wim; Fauci, Anthony S.

In: Journal of the American Medical Association, Vol. 257, No. 19, 15.05.1987, p. 2617-2621.

Research output: Contribution to journalArticle

Quinn, Thomas C ; Piot, Peter ; Mccormick, Joseph B. ; Feinsod, Fred M. ; Taelman, Henry ; Kapita, Bela ; Stevens, Wim ; Fauci, Anthony S. / Serologic and Immunologic Studies in Patients With AIDS in North America and Africa : The Potential Role of Infectious Agents as Cofactors in Human Immunodeficiency Virus Infection. In: Journal of the American Medical Association. 1987 ; Vol. 257, No. 19. pp. 2617-2621.
@article{3762ae8e1ec24b63a6661f8fea4b4d11,
title = "Serologic and Immunologic Studies in Patients With AIDS in North America and Africa: The Potential Role of Infectious Agents as Cofactors in Human Immunodeficiency Virus Infection",
abstract = "Serologic and immunologic studies were performed in 38 African and 60 US patients with acquired immunodeficiency syndrome (AIDS), 100 African and 100 US heterosexual men and women, and 100 US homosexual men to examine the potential role of infectious agents in human immunodeficiency virus (HIV) infection. There were no significant differences in the prevalence of antibodies to cytomegalovirus, Epstein-Barr virus, hepatitis A and B viruses, herpes simplex virus, syphilis, and toxoplasmosis among the African and US patients with AIDS, African heterosexual controls, and US homosexual men. However, these four groups all demonstrated a significantly greater prevalence of antibodies to each of these infectious agents compared with US heterosexual men. Immunologic studies demonstrated a significant elevation of activated lymphocytes (HLA-DR and T3 positive) and immune complexes in both AIDS populations and African heterosexual and US homosexual populations, compared with the US heterosexual population. These data demonstrate that the immune systems of African heterosexuals, similar to those of US homosexual men, are in a chronically activated state associated with chronic viral and parasitic antigenic exposure, which may cause them to be particularly susceptible to HIV infection or disease progression.",
author = "Quinn, {Thomas C} and Peter Piot and Mccormick, {Joseph B.} and Feinsod, {Fred M.} and Henry Taelman and Bela Kapita and Wim Stevens and Fauci, {Anthony S.}",
year = "1987",
month = "5",
day = "15",
doi = "10.1001/jama.1987.03390190095027",
language = "English (US)",
volume = "257",
pages = "2617--2621",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "19",

}

TY - JOUR

T1 - Serologic and Immunologic Studies in Patients With AIDS in North America and Africa

T2 - The Potential Role of Infectious Agents as Cofactors in Human Immunodeficiency Virus Infection

AU - Quinn, Thomas C

AU - Piot, Peter

AU - Mccormick, Joseph B.

AU - Feinsod, Fred M.

AU - Taelman, Henry

AU - Kapita, Bela

AU - Stevens, Wim

AU - Fauci, Anthony S.

PY - 1987/5/15

Y1 - 1987/5/15

N2 - Serologic and immunologic studies were performed in 38 African and 60 US patients with acquired immunodeficiency syndrome (AIDS), 100 African and 100 US heterosexual men and women, and 100 US homosexual men to examine the potential role of infectious agents in human immunodeficiency virus (HIV) infection. There were no significant differences in the prevalence of antibodies to cytomegalovirus, Epstein-Barr virus, hepatitis A and B viruses, herpes simplex virus, syphilis, and toxoplasmosis among the African and US patients with AIDS, African heterosexual controls, and US homosexual men. However, these four groups all demonstrated a significantly greater prevalence of antibodies to each of these infectious agents compared with US heterosexual men. Immunologic studies demonstrated a significant elevation of activated lymphocytes (HLA-DR and T3 positive) and immune complexes in both AIDS populations and African heterosexual and US homosexual populations, compared with the US heterosexual population. These data demonstrate that the immune systems of African heterosexuals, similar to those of US homosexual men, are in a chronically activated state associated with chronic viral and parasitic antigenic exposure, which may cause them to be particularly susceptible to HIV infection or disease progression.

AB - Serologic and immunologic studies were performed in 38 African and 60 US patients with acquired immunodeficiency syndrome (AIDS), 100 African and 100 US heterosexual men and women, and 100 US homosexual men to examine the potential role of infectious agents in human immunodeficiency virus (HIV) infection. There were no significant differences in the prevalence of antibodies to cytomegalovirus, Epstein-Barr virus, hepatitis A and B viruses, herpes simplex virus, syphilis, and toxoplasmosis among the African and US patients with AIDS, African heterosexual controls, and US homosexual men. However, these four groups all demonstrated a significantly greater prevalence of antibodies to each of these infectious agents compared with US heterosexual men. Immunologic studies demonstrated a significant elevation of activated lymphocytes (HLA-DR and T3 positive) and immune complexes in both AIDS populations and African heterosexual and US homosexual populations, compared with the US heterosexual population. These data demonstrate that the immune systems of African heterosexuals, similar to those of US homosexual men, are in a chronically activated state associated with chronic viral and parasitic antigenic exposure, which may cause them to be particularly susceptible to HIV infection or disease progression.

UR - http://www.scopus.com/inward/record.url?scp=84944372866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944372866&partnerID=8YFLogxK

U2 - 10.1001/jama.1987.03390190095027

DO - 10.1001/jama.1987.03390190095027

M3 - Article

VL - 257

SP - 2617

EP - 2621

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 19

ER -